TrademarkDir
LUMOS PHARMA
LIVE

Serial Number

97033399

Owner

LUMOS PHARMA, LLC

Attorney

Luke T. Mohrhauser

First Use Date

Dec 22, 2014

Filing Date

Sep 17, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

LUMOS PHARMA Trademark

Serial Number: 97033399

LUMOS PHARMA is a trademark filed by LUMOS PHARMA, LLC on September 17, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

LUMOS PHARMA, LLC (2 trademarks)

2503 SOUTH LOOP DRIVE
AMES, IA 50010

Entity Type: 16

Lumos Pharma, Inc.

4200 Marathon Blvd., Ste. 200
Austin, TX 78756

Entity Type: 03

Trademark Details

Filing Date

September 17, 2021

Registration Date

Not Registered

First Use Anywhere

December 22, 2014

First Use in Commerce

December 22, 2014

Goods & Services

Therapeutic pharmaceuticals to treat rare diseases in children, namely Pediatric Growth Hormone Deficiency (PGHD)

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 12, 2026 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 31, 2025 RCSC
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 2, 2025 ASGN
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 28, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 28, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 28, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 23, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 7, 2023 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 8, 2023 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 9, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 9, 2022 GNSL
SUSPENSION LETTER WRITTEN
Dec 9, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 30, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 29, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 29, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 22, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jun 22, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jun 22, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 21, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 22, 2021 NWOS
NEW APPLICATION ENTERED
Sep 21, 2021 NWAP

Related Trademarks

More from this Owner

LUMOS PHARMA

LUMOS PHARMA